Session » Antiphospholipid Syndrome: Clinical
-
Abstract Number: 2182
Increased Risk of Livedo Reticularis Associated with Antiphospholipid Antibodies in Patients with Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis
-
Abstract Number: 2183
Clinical and Epidemiological Correlates of the Adjusted Global Anti-Phospholipid Syndrome Score in a Large Cohort of Chinese APS Patients
-
Abstract Number: 2184
Non-Criteria Clinical Manifestations in Antiphospholipid Syndrome: Clinical Behavior and Association with Damage Accrual
-
Abstract Number: 2185
Small but Clinically Insignificant Decreases in Antiphospholipid Antibody Titers Occur in aPL-Positive Patients during Pregnancy
-
Abstract Number: 2186
The Role of Hydroxychloroquine Treatment on Pregnancy Outcome in Women with Antiphospholipid Antibodies
-
Abstract Number: 2187
Anti-Phosholipid Antibodies and Female Infertility: A Systematic Revision of Literature
-
Abstract Number: 2188
Antiphospholipid Antibodies and the Risk of Damage Accrual in Systemic Lupus Erythematosus
-
Abstract Number: 2191
Increased Risk of Acute and Chronic Renal Lesions Associated with Antiphospholipid Antibodies in Patients with Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis
-
Abstract Number: 2192
Increased Risk of Thrombocytopenia Associated with Antiphospholipid Antibodies in Patients with Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis
-
Abstract Number: 2193
Increased Risk of Hemolytic Anemia Associated with Antiphospholipid Antibodies in Patients with Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis
-
Abstract Number: 2194
Anticoagulation and Longterm Outcomes in Patients with Renal Artery Stenosis and Antiphospholipid Syndrome
-
Abstract Number: 2195
Long Term Outcome of Primary Antiphospholipid Syndrome Patients: A Multicenter Study
-
Abstract Number: 2196
Association Between Antiphospholipid Antibodies and All-Cause Mortality Among End Stage Renal Disease Patients with and without SLE
-
Abstract Number: 2198
Antiphospholipid Syndrome Alliance for Clinical Trials & International Networking Clinical Database and Repository Analysis: Determinants of Thrombosis in Patients Presenting with Obstetric APS
-
Abstract Number: 2199
in Vivo Ubiquinol Supplementation Reduces the Pro-Atherothrombotic Status in Antiphospholipid Syndrome Patients. Preliminary Results of a Clinical Trial